STOCKHOLDERS' EQUITY (Tables)

12 Months Ended

Dec. 31, 2021

STOCKHOLDERS' EQUITY

Schedule Of Share Based Compensation Stock Options Activity

The summary of the stock option activity for the years ended December 31, 2021, 2020 and 2019 is as follows:

				Weighted
		Weighted		Average
		Average		Remaining
		Exercise		Contractual
	Shares	per Share		Life (Years)
Outstanding January 1, 2019	3,658,462	$	5.82	7.0
Granted	1,557,300	$	7.19	9.5
Forfeited	(747,671)	$	7.39	—
Expired	(16,320)	$	4.16	—
Exercised	(233,582)	$	4.09	—
Outstanding, December 31, 2019	4,218,189	$	6.16	7.0
Granted	1,579,106	$	6.37	9.0
Forfeited	(34,644)	$	7.50	—
Expired	(226,440)	$	5.60	—
Exercised	(371,007)	$	4.46	—
Outstanding, December 31, 2020	5,165,204	$	6.36	7.26
Granted	2,051,980	$	8.78	9.30
Forfeited	(138,037)	$	6.73	—
Expired	(21,756)	$	7.46	—
Exercised	(171,413)	$	5.73	—
Outstanding, December 31, 2021	6,885,978	$	7.09	7.15

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

The fair value of each stock option was estimated using the Black Scholes pricing model which takes the following factors into account.

				Current Price
				of the
				Underlying
				Stock and its
	Grant Date		Expected Life	Expected				Risk Free
	Exercise Price		of the Stock	Volatility		Expected		Interest Rate
Year - Ended	Range		Option	Range		Dividends		Range
December 31, 2019	$	3.84 to $8.25 per share	10 years	61.9% to 74.3	%	0	%	1.40% to 2.61	%
December 31, 2020	$	5.00 - $10.58 per share	10 years	61.7% to 69.8	%	0	%	0.28% to 0.96	%
December 31, 2021	$	4.26 - $11.39 per share	10 years	58.2% to 60.7	%	0	%	0.47% to 1.39	%

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range

In addition, the Company recognizes forfeitures as they occur.

The intrinsic value is calculated at the difference between the market value as of December 31, 2021 of $4.19 and the exercise price of the shares.

Options Outstanding
	Number	Weighted		Weighted
Range of	Outstanding at	Average		Average	Aggregate
Exercise	December 31,	Exercise		Remaining	Intrinsic
Price	2021	Price		Life (Years)	Value
$2.65 - $14.50	6,885,978	$	7.09	7.15	$	166,383

Options Exercisable
Number	Weighted
Exercisable at	Average		Aggregate
December 31,	Exercise		Intrinsic
2021	Price		Value
3,891,132	$	6.45	$	166,383

Schedule Of Non vested Share Activity

The summary of the status of the Company’s non-vested options for the year ended December 31, 2021 is as follows:

		Weighted
		Average
		Grant Date
	Shares	Fair Value
Non-vested, January 1, 2021	1,998,117	$	4.12
Granted	2,051,980		5.26
Forfeited	(138,037)		4.05
Vested	(917,214)		4.34
Non-vested, December 31, 2021	2,994,846	$	4.68

Schedule of Share-based Compensation, Restricted Stock Units Award Activity

The following table is a summary of these restricted stock units:

	Board of	Executive	Other
	Directors	Management	Employees	Total	Intrinsic Value
December 31, 2018	277,200	724,500	1,002,300	2,004,000
Granted 2019	—	—	264,500	264,500
Forfeited 2019	—	(120,000)	(61,750)	(181,750)
December 31, 2019	277,200	604,500	1,205,050	2,086,750	$	8,033,988
Granted 2020	—	120,000	265,700	385,700
Forfeited 2020	—	—	(25,250)	(25,250)
December 31, 2020	277,200	724,500	1,445,500	2,447,200	$	19,504,184
Granted 2021	—	—	396,000	396,000
Forfeited 2021	—	—	(132,000)	(132,000)
December 31, 2021	277,200	724,500	1,709,500	2,711,200	$	11,359,928

Schedule Of Restricted Stock Unit Activity

The following table outlines the restricted stock unit activity for the year ended December 31, 2021:

		Weighted
		Average
		Grant Date
	Shares	Fair Value
Non-vested, January 1, 2021	173,972	$	6.52
Granted	327,515	$	8.65
Vested	(196,525)	$	7.64
Non-vested, December 31, 2021	304,962	$	8.08